2025 EVENT SITE
WMIF MAIN SITETuesday, September 16, 2025
09:10 AM - 09:50 AM
Over the past several decades transplantation has been established as a viable, last resort for instances of organ failure. However, the remarkable success rate of these procedures has become limited by the availability of healthy source organs. Taking advantage of the surgical knowledge gained over performance of thousands of transplants combined with greater understanding of immunology and novel post procedure treatment protocols, we are on the verge of solving the basic limitation of transplantable organ availability. This session will describe both the history and the near-term future of how this feat is expected to be accomplished.
Moderator
Joren Madsen, MD, PhD,
Director, Transplant Center, Massachusetts General Hospital;
Paul S. Russell/Warner-Lambert Professor of Surgery, Harvard Medical School
Speakers
Mike Curtis,
President & CEO, eGenesis
Pablo Legorreta,
Founder, CEO & Chairman, Royalty Pharma
Leonardo Riella, MD, PhD,
Medical Director of Kidney Transplantation, Massachusetts General Hospital;
Harold and Ellen Danser Endowed Chair in Transplantation, Harvard Medical School
Julie Sunderland,
Founder & President, Oriane Consulting